Jiqiu Wang

Title: Innovations of Jiqiu Wang in Metabolic Disease Treatment

Introduction

Jiqiu Wang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of metabolic disease treatment through his innovative research and patented inventions. With a total of two patents, Wang's work focuses on developing strains and medicaments aimed at preventing and treating obesity and related diseases.

Latest Patents

Wang's latest patents include a strain specifically designed for preventing and treating metabolic diseases. This strain, named SSYD-3, has been assigned the accession number CGMCC No. 14764. It demonstrates superior fermentation performance, storage stability, acid and bile resistance compared to the existing strain ATCC BAA835. Additionally, Wang has developed a medicament for the treatment or prevention of obesity and obesity-related diseases. This patent encompasses a pharmaceutical composition, a medicament, a food product, and an animal feed, all aimed at addressing obesity and its related health issues.

Career Highlights

Throughout his career, Jiqiu Wang has worked with reputable organizations such as Sph Sine Pharmaceutical Laboratories Co., Ltd and the Shanghai Institute of Endocrine and Metabolic Diseases. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Wang has collaborated with notable colleagues, including Guang Ning and Weiqing Wang. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Jiqiu Wang's innovative contributions to the treatment of metabolic diseases highlight his dedication to improving health outcomes. His patents reflect a commitment to advancing medical science and addressing critical health challenges.